Steven E. Hyman, M.D., (Chair) is Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. He directs the Stanley Center for Psychiatric Research at the Broad Institute of Harvard and MIT, which is focused on large-scale genetic studies of schizophrenia, bipolar disorder, autism, and other neurodevelopmental disorders and the use of genetic information to study pathogenesis and therapeutics. He joined the Broad after a decade of service as provost of Harvard University. As provost he served as Harvard’s chief academic officer, and also had a special focus on the development of collaborative initiatives that span multiple disciplines and cross institutional boundaries. From 1996 to 2001, he served as director of the U.S. National Institute of Mental Health (NIMH). At NIMH he emphasized investment in basic neuroscience and emerging genetic technologies, and also initiated a series of large clinical trials as well as a program of clinical trials for children, a population about which little was known with certainty. In the laboratory he studied the control of neural gene expression by neurotransmitters, especially dopamine, with the goal of understanding mechanisms that regulate emotion and motivation in health and illness. Hyman is a member of the Institute of Medicine of the U.S. National Academies of Science where he serves on the Council, on the Board of Health Sciences Policy, and as Chair of the Neuroscience Forum. He is the editor of the Annual Review of Neuroscience and founding president of the International Neuroethics Society. He is also a fellow of the American Academy of Arts and Sciences, a fellow of the American Association for the Advancement of Science, a fellow of the American College of Neuropsychopharmacology, and a Distinguished Life Fellow of the American Psychiatric Association.